FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-12

AUTHORS

Aziz Zaanan, Isabelle Trouilloud, Theofano Markoutsaki, Mélanie Gauthier, Anne-Claire Dupont-Gossart, Thierry Lecomte, Thomas Aparicio, Pascal Artru, Anne Thirot-Bidault, Fanny Joubert, Daniella Fanica, Julien Taieb

ABSTRACT

BACKGROUND: FOLFOX second-line treatment seems to be a validated option for patients with pancreatic cancer (PC) progressing after gemcitabine chemotherapy. However, other therapeutics strategy has developed in first-line therapy, as the FIRGEM phase II study that evaluated gemcitabine alone versus FOLFIRI.3 alternating with gemcitabine every two months. The present study assessed the efficacy and safety of FOLFOX after failure of the first-line therapy used in the FIRGEM study. METHODS: In this prospective observational cohort study, we analysed all consecutive patients who received second-line chemotherapy with FOLFOX among 98 patients with metastatic PC included in the FIRGEM study. Progression-free survival (PFS) and overall survival (OS) were estimated from the start of second-line chemotherapy using the Kaplan-Meier method. RESULTS: Among 46 patients who received second-line chemotherapy, 27 patients (male, 55%; median age, 61 years; performance status (PS) 0-1, 44%) were treated with FOLFOX after progression to first-line gemcitabine alone (n = 20) or FOLFIRI.3 alternating with gemcitabine (n = 7). Grade 3 toxicity was observed in 33% of patients (no grade 4 toxicity). At the end of follow-up, all patients had progressed and 25 had died. No objective response was observed, and disease control rate was 36%. Median PFS and OS were 1.7 and 4.3 months, respectively. In multivariate analysis, PS was the only independent prognostic factor. For patients PS 0-1 versus 2-3, median PFS was 3.0 versus 1.2 months (log rank, p = 0.002), and median OS was 5.9 versus 2.6 months (log rank, p = 0.001). CONCLUSIONS: This study suggests that FOLFOX second-line therapy offered interesting efficacy results with an acceptable toxicity profile in metastatic PC patients with a good PS. More... »

PAGES

441

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2407-14-441

DOI

http://dx.doi.org/10.1186/1471-2407-14-441

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018864975

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24929865


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leucovorin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoplatinum Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Paris Descartes University", 
          "id": "https://www.grid.ac/institutes/grid.10992.33", 
          "name": [
            "Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015, Paris, France", 
            "University of Paris Descartes, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zaanan", 
        "givenName": "Aziz", 
        "id": "sg:person.0632676606.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632676606.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Paris Descartes University", 
          "id": "https://www.grid.ac/institutes/grid.10992.33", 
          "name": [
            "Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015, Paris, France", 
            "University of Paris Descartes, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trouilloud", 
        "givenName": "Isabelle", 
        "id": "sg:person.01061023113.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061023113.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Europ\u00e9en Georges-Pompidou", 
          "id": "https://www.grid.ac/institutes/grid.414093.b", 
          "name": [
            "Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Markoutsaki", 
        "givenName": "Theofano", 
        "id": "sg:person.01106027525.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106027525.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Biostatistic and Quality of Life Unit, Georges Fran\u00e7ois Leclerc Center, Dijon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gauthier", 
        "givenName": "M\u00e9lanie", 
        "id": "sg:person.01257672243.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257672243.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Hepatogastroenterology, Jean Minjoz Hospital, Besan\u00e7on, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dupont-Gossart", 
        "givenName": "Anne-Claire", 
        "id": "sg:person.01046232522.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046232522.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Department of Hepatogastroenterology, Trousseau Hospital, University of Fran\u00e7ois-Rabelais, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lecomte", 
        "givenName": "Thierry", 
        "id": "sg:person.01143615757.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143615757.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Avicenne", 
          "id": "https://www.grid.ac/institutes/grid.413780.9", 
          "name": [
            "Department of Gastroenterology and Digestive Oncology, Avicenne Hospital, HUPSSD, AP-HP, University of Paris 13, Sorbonne Paris Cit\u00e9, Bobigny, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aparicio", 
        "givenName": "Thomas", 
        "id": "sg:person.01303311306.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303311306.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Gastroenterology and Digestive Oncology, Jean Mermoz Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Artru", 
        "givenName": "Pascal", 
        "id": "sg:person.01023010340.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023010340.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bic\u00eatre Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413784.d", 
          "name": [
            "Department of Hepatogastroenterology, Bic\u00eatre Hospital, AP-HP, Kremlin Bic\u00eatre, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thirot-Bidault", 
        "givenName": "Anne", 
        "id": "sg:person.01147304743.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147304743.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Europ\u00e9en Georges-Pompidou", 
          "id": "https://www.grid.ac/institutes/grid.414093.b", 
          "name": [
            "Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joubert", 
        "givenName": "Fanny", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Europ\u00e9en Georges-Pompidou", 
          "id": "https://www.grid.ac/institutes/grid.414093.b", 
          "name": [
            "Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fanica", 
        "givenName": "Daniella", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Paris Descartes University", 
          "id": "https://www.grid.ac/institutes/grid.10992.33", 
          "name": [
            "Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015, Paris, France", 
            "University of Paris Descartes, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taieb", 
        "givenName": "Julien", 
        "id": "sg:person.01203564254.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203564254.60"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2006.07.9525", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005176755"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinre.2011.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007327058"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/gut.2010.216135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008372915"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-46502", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009543433"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22852", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009856216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605374", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010346465", 
          "https://doi.org/10.1038/sj.bjc.6605374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605374", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010346465", 
          "https://doi.org/10.1038/sj.bjc.6605374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0399-8320(06)73188-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010699520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2011.04.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011197768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000134477", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021599937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2009.12.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021779666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1011923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022967950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028056239", 
          "https://doi.org/10.1038/sj.bjc.6603026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028056239", 
          "https://doi.org/10.1038/sj.bjc.6603026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl427", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032310392"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1179/joc.2008.20.4.509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032561672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-005-1446-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033159286", 
          "https://doi.org/10.1007/s10637-005-1446-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-005-1446-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033159286", 
          "https://doi.org/10.1007/s10637-005-1446-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-005-1446-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033159286", 
          "https://doi.org/10.1007/s10637-005-1446-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdh098", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033792091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-012-1875-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035705631", 
          "https://doi.org/10.1007/s00280-012-1875-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000197769", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036414602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23810", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043582157"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31817be5a9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049786467"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31817be5a9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049786467"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31817be5a9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049786467"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.6.2403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083106816"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12", 
    "datePublishedReg": "2014-12-01", 
    "description": "BACKGROUND: FOLFOX second-line treatment seems to be a validated option for patients with pancreatic cancer (PC) progressing after gemcitabine chemotherapy. However, other therapeutics strategy has developed in first-line therapy, as the FIRGEM phase II study that evaluated gemcitabine alone versus FOLFIRI.3 alternating with gemcitabine every two months. The present study assessed the efficacy and safety of FOLFOX after failure of the first-line therapy used in the FIRGEM study.\nMETHODS: In this prospective observational cohort study, we analysed all consecutive patients who received second-line chemotherapy with FOLFOX among 98 patients with metastatic PC included in the FIRGEM study. Progression-free survival (PFS) and overall survival (OS) were estimated from the start of second-line chemotherapy using the Kaplan-Meier method.\nRESULTS: Among 46 patients who received second-line chemotherapy, 27 patients (male, 55%; median age, 61 years; performance status (PS) 0-1, 44%) were treated with FOLFOX after progression to first-line gemcitabine alone (n = 20) or FOLFIRI.3 alternating with gemcitabine (n = 7). Grade 3 toxicity was observed in 33% of patients (no grade 4 toxicity). At the end of follow-up, all patients had progressed and 25 had died. No objective response was observed, and disease control rate was 36%. Median PFS and OS were 1.7 and 4.3 months, respectively. In multivariate analysis, PS was the only independent prognostic factor. For patients PS 0-1 versus 2-3, median PFS was 3.0 versus 1.2 months (log rank, p = 0.002), and median OS was 5.9 versus 2.6 months (log rank, p = 0.001).\nCONCLUSIONS: This study suggests that FOLFOX second-line therapy offered interesting efficacy results with an acceptable toxicity profile in metastatic PC patients with a good PS.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1471-2407-14-441", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study", 
    "pagination": "441", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "59e2da865841424f109c3ed617fbe34897bad29ea98e1fc734ade3440f95dbf4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24929865"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2407-14-441"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018864975"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2407-14-441", 
      "https://app.dimensions.ai/details/publication/pub.1018864975"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1471-2407-14-441"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-14-441'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-14-441'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-14-441'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-14-441'


 

This table displays all metadata directly associated to this object as RDF triples.

284 TRIPLES      21 PREDICATES      64 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2407-14-441 schema:about N251e859b8d414b6ea05d99bb996a2fc0
2 N44898ff0e3744d7bbbfa259f181165d0
3 N727417efa68145ac865cbe396f64eba9
4 N8dbd131414b94c3f828c6797d0064723
5 N98f787d46dfa49d2b004271c40eb886f
6 N9d88dbdbb83a417d83cc2ecf844d9194
7 Na08bc80db79048569d3e4cac7a9556b0
8 Na4fccb3dc334432a8683f77bf94cbd2e
9 Naabbaf4395be40068812f111524605c2
10 Nb5de50d2d89e4acd8bd4b93031d34163
11 Nb907937485ed475aa296207590f70c83
12 Nbc792440178b42eb9370f64632aaf804
13 Nc4bc6689fd004a0ca926382445e98182
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N77837e72387e46ec8902dfb168f95643
17 schema:citation sg:pub.10.1007/s00280-012-1875-1
18 sg:pub.10.1007/s10637-005-1446-y
19 sg:pub.10.1038/sj.bjc.6603026
20 sg:pub.10.1038/sj.bjc.6605374
21 https://doi.org/10.1002/cncr.22852
22 https://doi.org/10.1002/cncr.23810
23 https://doi.org/10.1016/j.clinre.2011.02.002
24 https://doi.org/10.1016/j.ejca.2009.12.014
25 https://doi.org/10.1016/j.ejca.2011.04.011
26 https://doi.org/10.1016/s0399-8320(06)73188-8
27 https://doi.org/10.1056/nejmoa1011923
28 https://doi.org/10.1081/cnv-46502
29 https://doi.org/10.1093/annonc/mdh098
30 https://doi.org/10.1093/annonc/mdl427
31 https://doi.org/10.1093/jnci/92.3.205
32 https://doi.org/10.1097/coc.0b013e31817be5a9
33 https://doi.org/10.1136/gut.2010.216135
34 https://doi.org/10.1159/000134477
35 https://doi.org/10.1159/000197769
36 https://doi.org/10.1179/joc.2008.20.4.509
37 https://doi.org/10.1200/jco.1997.15.6.2403
38 https://doi.org/10.1200/jco.2006.07.9525
39 schema:datePublished 2014-12
40 schema:datePublishedReg 2014-12-01
41 schema:description BACKGROUND: FOLFOX second-line treatment seems to be a validated option for patients with pancreatic cancer (PC) progressing after gemcitabine chemotherapy. However, other therapeutics strategy has developed in first-line therapy, as the FIRGEM phase II study that evaluated gemcitabine alone versus FOLFIRI.3 alternating with gemcitabine every two months. The present study assessed the efficacy and safety of FOLFOX after failure of the first-line therapy used in the FIRGEM study. METHODS: In this prospective observational cohort study, we analysed all consecutive patients who received second-line chemotherapy with FOLFOX among 98 patients with metastatic PC included in the FIRGEM study. Progression-free survival (PFS) and overall survival (OS) were estimated from the start of second-line chemotherapy using the Kaplan-Meier method. RESULTS: Among 46 patients who received second-line chemotherapy, 27 patients (male, 55%; median age, 61 years; performance status (PS) 0-1, 44%) were treated with FOLFOX after progression to first-line gemcitabine alone (n = 20) or FOLFIRI.3 alternating with gemcitabine (n = 7). Grade 3 toxicity was observed in 33% of patients (no grade 4 toxicity). At the end of follow-up, all patients had progressed and 25 had died. No objective response was observed, and disease control rate was 36%. Median PFS and OS were 1.7 and 4.3 months, respectively. In multivariate analysis, PS was the only independent prognostic factor. For patients PS 0-1 versus 2-3, median PFS was 3.0 versus 1.2 months (log rank, p = 0.002), and median OS was 5.9 versus 2.6 months (log rank, p = 0.001). CONCLUSIONS: This study suggests that FOLFOX second-line therapy offered interesting efficacy results with an acceptable toxicity profile in metastatic PC patients with a good PS.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree true
45 schema:isPartOf N004b82d99b7a459b90052d8e7e5e0860
46 Nb5e82c0cee46477b8f0ac5d8cf207a71
47 sg:journal.1024632
48 schema:name FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
49 schema:pagination 441
50 schema:productId N44dacaba9d29402f99cedb124c18521f
51 N77f3cb5268e540408f079d2dbd18c7ee
52 Nac82fb18d44a4e2496bd3361604cb6bf
53 Nb34d15a46ec146649a426e70eb6c91e1
54 Nc3e934857efc4bd4aed9c1f7cc79f17d
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018864975
56 https://doi.org/10.1186/1471-2407-14-441
57 schema:sdDatePublished 2019-04-10T16:42
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N4987a4bac19544a280d43878faa4bfe3
60 schema:url http://link.springer.com/10.1186%2F1471-2407-14-441
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N004b82d99b7a459b90052d8e7e5e0860 schema:issueNumber 1
65 rdf:type schema:PublicationIssue
66 N152c3529dac8417694c6b1316698596f rdf:first sg:person.01023010340.72
67 rdf:rest Nced59a782a614261bcbe4012e7285528
68 N1d322ef94ea2497abb5066fdccf9cd5e schema:affiliation https://www.grid.ac/institutes/grid.414093.b
69 schema:familyName Fanica
70 schema:givenName Daniella
71 rdf:type schema:Person
72 N1e65560cddb94194906c3f4940a502d2 rdf:first Ne62f2e273f2141c4b948b6fd7a77ad61
73 rdf:rest N4eb7f2ae42df404586c37f6f120ec08d
74 N251e859b8d414b6ea05d99bb996a2fc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Middle Aged
76 rdf:type schema:DefinedTerm
77 N425bbecacf6046e290712e92f8b60e8c rdf:first sg:person.01106027525.74
78 rdf:rest Na1c98dd4f4194e5685cfc0b6f90a42be
79 N44898ff0e3744d7bbbfa259f181165d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Neoplasm Metastasis
81 rdf:type schema:DefinedTerm
82 N44dacaba9d29402f99cedb124c18521f schema:name dimensions_id
83 schema:value pub.1018864975
84 rdf:type schema:PropertyValue
85 N4987a4bac19544a280d43878faa4bfe3 schema:name Springer Nature - SN SciGraph project
86 rdf:type schema:Organization
87 N4b5bac0b9284463fa86010e4e8292e70 rdf:first sg:person.01143615757.53
88 rdf:rest Nabfc9fd28ee64114982ad67aaaa7e964
89 N4eb7f2ae42df404586c37f6f120ec08d rdf:first N1d322ef94ea2497abb5066fdccf9cd5e
90 rdf:rest Nc556cab21857449da166a014f4c051b7
91 N6b559a367df5456aaccc3b45bd0d2342 schema:name Biostatistic and Quality of Life Unit, Georges François Leclerc Center, Dijon, France
92 rdf:type schema:Organization
93 N727417efa68145ac865cbe396f64eba9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Aged
95 rdf:type schema:DefinedTerm
96 N75382f29ae9046a68af2764e526f37f3 rdf:first sg:person.01046232522.51
97 rdf:rest N4b5bac0b9284463fa86010e4e8292e70
98 N77837e72387e46ec8902dfb168f95643 rdf:first sg:person.0632676606.59
99 rdf:rest Nbd7cea02333b4f54b8cedb79ff711332
100 N77f3cb5268e540408f079d2dbd18c7ee schema:name readcube_id
101 schema:value 59e2da865841424f109c3ed617fbe34897bad29ea98e1fc734ade3440f95dbf4
102 rdf:type schema:PropertyValue
103 N8dbd131414b94c3f828c6797d0064723 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Treatment Outcome
105 rdf:type schema:DefinedTerm
106 N98f787d46dfa49d2b004271c40eb886f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Male
108 rdf:type schema:DefinedTerm
109 N9d88dbdbb83a417d83cc2ecf844d9194 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Antineoplastic Combined Chemotherapy Protocols
111 rdf:type schema:DefinedTerm
112 Na08bc80db79048569d3e4cac7a9556b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Prognosis
114 rdf:type schema:DefinedTerm
115 Na1c98dd4f4194e5685cfc0b6f90a42be rdf:first sg:person.01257672243.78
116 rdf:rest N75382f29ae9046a68af2764e526f37f3
117 Na4fccb3dc334432a8683f77bf94cbd2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 Naabbaf4395be40068812f111524605c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Fluorouracil
122 rdf:type schema:DefinedTerm
123 Nabfc9fd28ee64114982ad67aaaa7e964 rdf:first sg:person.01303311306.39
124 rdf:rest N152c3529dac8417694c6b1316698596f
125 Nac82fb18d44a4e2496bd3361604cb6bf schema:name doi
126 schema:value 10.1186/1471-2407-14-441
127 rdf:type schema:PropertyValue
128 Nb34d15a46ec146649a426e70eb6c91e1 schema:name nlm_unique_id
129 schema:value 100967800
130 rdf:type schema:PropertyValue
131 Nb5de50d2d89e4acd8bd4b93031d34163 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Female
133 rdf:type schema:DefinedTerm
134 Nb5e82c0cee46477b8f0ac5d8cf207a71 schema:volumeNumber 14
135 rdf:type schema:PublicationVolume
136 Nb907937485ed475aa296207590f70c83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Leucovorin
138 rdf:type schema:DefinedTerm
139 Nbc792440178b42eb9370f64632aaf804 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Pancreatic Neoplasms
141 rdf:type schema:DefinedTerm
142 Nbd7cea02333b4f54b8cedb79ff711332 rdf:first sg:person.01061023113.42
143 rdf:rest N425bbecacf6046e290712e92f8b60e8c
144 Nc3e934857efc4bd4aed9c1f7cc79f17d schema:name pubmed_id
145 schema:value 24929865
146 rdf:type schema:PropertyValue
147 Nc4bc6689fd004a0ca926382445e98182 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Organoplatinum Compounds
149 rdf:type schema:DefinedTerm
150 Nc556cab21857449da166a014f4c051b7 rdf:first sg:person.01203564254.60
151 rdf:rest rdf:nil
152 Ncbdcd594970a4bfc8db34971ad4ea383 schema:name Department of Gastroenterology and Digestive Oncology, Jean Mermoz Hospital, Lyon, France
153 rdf:type schema:Organization
154 Nced59a782a614261bcbe4012e7285528 rdf:first sg:person.01147304743.49
155 rdf:rest N1e65560cddb94194906c3f4940a502d2
156 Ne62f2e273f2141c4b948b6fd7a77ad61 schema:affiliation https://www.grid.ac/institutes/grid.414093.b
157 schema:familyName Joubert
158 schema:givenName Fanny
159 rdf:type schema:Person
160 Nfd4a157185fa471a9814567f5a26a2b0 schema:name Department of Hepatogastroenterology, Jean Minjoz Hospital, Besançon, France
161 rdf:type schema:Organization
162 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
163 schema:name Medical and Health Sciences
164 rdf:type schema:DefinedTerm
165 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
166 schema:name Oncology and Carcinogenesis
167 rdf:type schema:DefinedTerm
168 sg:journal.1024632 schema:issn 1471-2407
169 schema:name BMC Cancer
170 rdf:type schema:Periodical
171 sg:person.01023010340.72 schema:affiliation Ncbdcd594970a4bfc8db34971ad4ea383
172 schema:familyName Artru
173 schema:givenName Pascal
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023010340.72
175 rdf:type schema:Person
176 sg:person.01046232522.51 schema:affiliation Nfd4a157185fa471a9814567f5a26a2b0
177 schema:familyName Dupont-Gossart
178 schema:givenName Anne-Claire
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046232522.51
180 rdf:type schema:Person
181 sg:person.01061023113.42 schema:affiliation https://www.grid.ac/institutes/grid.10992.33
182 schema:familyName Trouilloud
183 schema:givenName Isabelle
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061023113.42
185 rdf:type schema:Person
186 sg:person.01106027525.74 schema:affiliation https://www.grid.ac/institutes/grid.414093.b
187 schema:familyName Markoutsaki
188 schema:givenName Theofano
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106027525.74
190 rdf:type schema:Person
191 sg:person.01143615757.53 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
192 schema:familyName Lecomte
193 schema:givenName Thierry
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143615757.53
195 rdf:type schema:Person
196 sg:person.01147304743.49 schema:affiliation https://www.grid.ac/institutes/grid.413784.d
197 schema:familyName Thirot-Bidault
198 schema:givenName Anne
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147304743.49
200 rdf:type schema:Person
201 sg:person.01203564254.60 schema:affiliation https://www.grid.ac/institutes/grid.10992.33
202 schema:familyName Taieb
203 schema:givenName Julien
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203564254.60
205 rdf:type schema:Person
206 sg:person.01257672243.78 schema:affiliation N6b559a367df5456aaccc3b45bd0d2342
207 schema:familyName Gauthier
208 schema:givenName Mélanie
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257672243.78
210 rdf:type schema:Person
211 sg:person.01303311306.39 schema:affiliation https://www.grid.ac/institutes/grid.413780.9
212 schema:familyName Aparicio
213 schema:givenName Thomas
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303311306.39
215 rdf:type schema:Person
216 sg:person.0632676606.59 schema:affiliation https://www.grid.ac/institutes/grid.10992.33
217 schema:familyName Zaanan
218 schema:givenName Aziz
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632676606.59
220 rdf:type schema:Person
221 sg:pub.10.1007/s00280-012-1875-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035705631
222 https://doi.org/10.1007/s00280-012-1875-1
223 rdf:type schema:CreativeWork
224 sg:pub.10.1007/s10637-005-1446-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1033159286
225 https://doi.org/10.1007/s10637-005-1446-y
226 rdf:type schema:CreativeWork
227 sg:pub.10.1038/sj.bjc.6603026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028056239
228 https://doi.org/10.1038/sj.bjc.6603026
229 rdf:type schema:CreativeWork
230 sg:pub.10.1038/sj.bjc.6605374 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010346465
231 https://doi.org/10.1038/sj.bjc.6605374
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1002/cncr.22852 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009856216
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1002/cncr.23810 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043582157
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/j.clinre.2011.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007327058
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/j.ejca.2009.12.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021779666
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/j.ejca.2011.04.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011197768
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/s0399-8320(06)73188-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010699520
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1056/nejmoa1011923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022967950
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1081/cnv-46502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009543433
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1093/annonc/mdh098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033792091
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1093/annonc/mdl427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032310392
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1097/coc.0b013e31817be5a9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049786467
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1136/gut.2010.216135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008372915
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1159/000134477 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021599937
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1159/000197769 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036414602
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1179/joc.2008.20.4.509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032561672
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1200/jco.1997.15.6.2403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083106816
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1200/jco.2006.07.9525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005176755
268 rdf:type schema:CreativeWork
269 https://www.grid.ac/institutes/grid.10992.33 schema:alternateName Paris Descartes University
270 schema:name Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015, Paris, France
271 University of Paris Descartes, Paris, France
272 rdf:type schema:Organization
273 https://www.grid.ac/institutes/grid.411167.4 schema:alternateName Centre Hospitalier Universitaire de Tours
274 schema:name Department of Hepatogastroenterology, Trousseau Hospital, University of François-Rabelais, Tours, France
275 rdf:type schema:Organization
276 https://www.grid.ac/institutes/grid.413780.9 schema:alternateName Hôpital Avicenne
277 schema:name Department of Gastroenterology and Digestive Oncology, Avicenne Hospital, HUPSSD, AP-HP, University of Paris 13, Sorbonne Paris Cité, Bobigny, France
278 rdf:type schema:Organization
279 https://www.grid.ac/institutes/grid.413784.d schema:alternateName Bicêtre Hospital
280 schema:name Department of Hepatogastroenterology, Bicêtre Hospital, AP-HP, Kremlin Bicêtre, France
281 rdf:type schema:Organization
282 https://www.grid.ac/institutes/grid.414093.b schema:alternateName Hôpital Européen Georges-Pompidou
283 schema:name Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015, Paris, France
284 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...